Paper384248
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
Hull R and 7 others. N Engl J Med, 1979. Cited by 594 papers, by iCite.
Cite this record
ConductScience Library. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. Papers, record 384248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/384248
- Disease
- venous thromboembolism33 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparin | Major topic |
| Thrombophlebitis | Major topic |
| Warfarin | Major topic |
| Acute Disease | |
| Clinical Trials as Topic | |
| Female | |
| Hemorrhage | |
| Humans | |
| Infusions, Parenteral | |
| Injections, Subcutaneous | |
| Male | |
| Middle Aged | |
| Prothrombin Time | |
| Recurrence | |
| Time Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04981327 | The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis | Results |
Source ClinicalTrials.gov
Cited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 594 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31858829 | Principal Component Analysis on Recurrent Venous Thromboembolism. | Clin Appl Thromb Hemost | 2019 | https://conductscience.org/library/papers/31858829 | PubMed |
| 30546748 | Dramatic response to low-dose rivaroxaban in an Asian patient with deep vein thrombosis and pulmonary embolism. | J Cardiol Cases | 2013 | https://conductscience.org/library/papers/30546748 | PubMed |
| 29791520 | Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension. | Clinics (Sao Paulo) | 2018 | https://conductscience.org/library/papers/29791520 | PubMed |
| 29399516 | Below-knee deep vein thrombosis (DVT): diagnostic and treatment patterns. | Cardiovasc Diagn Ther | 2017 | https://conductscience.org/library/papers/29399516 | PubMed |
| 29034033 | Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions. | Ann Vasc Dis | 2017 | https://conductscience.org/library/papers/29034033 | PubMed |
| 28737834 | Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28737834 | PubMed |
| 27699156 | Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. | Vasc Specialist Int | 2016 | https://conductscience.org/library/papers/27699156 | PubMed |
| 27167437 | New anticoagulants for the treatment of venous thromboembolism. | J Bras Pneumol | 2016 | https://conductscience.org/library/papers/27167437 | PubMed |
| 27122927 | Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. | Acta Cardiol Sin | 2016 | https://conductscience.org/library/papers/27122927 | PubMed |
| 25676529 | Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies. | Acad Emerg Med | 2015 | https://conductscience.org/library/papers/25676529 | PubMed |
| 25506267 | Treatment options for venous thromboembolism: lessons learnt from clinical trials. | Thromb J | 2014 | https://conductscience.org/library/papers/25506267 | PubMed |
| 25398066 | Sex differences in patients receiving anticoagulant therapy for venous thromboembolism. | Medicine (Baltimore) | 2014 | https://conductscience.org/library/papers/25398066 | PubMed |
| 25300410 | New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities. | Drugs | 2014 | https://conductscience.org/library/papers/25300410 | PubMed |
| 25092359 | Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25092359 | PubMed |
| 23829521 | Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. | Thromb J | 2013 | https://conductscience.org/library/papers/23829521 | PubMed |
| 23398560 | Sulfation patterns determine cellular internalization of heparin-like polysaccharides. | Mol Pharm | 2013 | https://conductscience.org/library/papers/23398560 | PubMed |
| 23344704 | Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach. | Curr Treat Options Cardiovasc Med | 2013 | https://conductscience.org/library/papers/23344704 | PubMed |
| 23049730 | Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. | PLoS One | 2012 | https://conductscience.org/library/papers/23049730 | PubMed |
| 22315268 | Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest | 2012 | https://conductscience.org/library/papers/22315268 | PubMed |
| 21765670 | Medical management of venous thromboembolic disease. | Ochsner J | 2000 | https://conductscience.org/library/papers/21765670 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| APIXABAN | CHEMBL231779 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL231779 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/384248
GET https://conductscience.org/api/papers/v1/384248/cited_by?page=2